Carotid Artery Stenting Outcomes in the Standard Risk Population for Carotid Endarterectomy

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1203 participants.

Also called NCT01445613

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,203 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01445613
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01445613. Allocation not applicable; no masking; primary purpose treatment. Start 2011-10 (registry gives no type); primary completion 2014-12 (actual). Results posted on 2016-04-12.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Carotid Artery Stenting Outcomes in the Standard Risk Population for Carotid Endarterectomy
Acronym
CANOPY
Condition
Carotid Artery Disease
Condition
Stroke
Condition
Amaurosis Fugax
Intervention (Device)
RX Acculink Carotid Stent System (RX Acculink)
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct01445613
Content hash
848bca3d8a5551bad2bf41d614e764570eb2af3d3ec4924bb45af43bffa1c583